Real-world Experience with Isatuximab in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): IONA-MM First Interim Analysis

被引:0
作者
Schwarzer, A. [1 ]
Schulte, C. [2 ]
Fries, S. [3 ]
Cavo, M. [4 ]
Tsukada, N. [5 ]
Tekle, C. [6 ]
Manasanch, E. E. [7 ]
Knauf, W. [8 ]
机构
[1] Onkopraxis Probstheida, Leipzig, Germany
[2] Gemeinsch Praxis Hamatol & Onkol, Dortmund, Germany
[3] Onkol Schwerpunktpraxis, Bamberg, Germany
[4] Univ Bologna, IRCCS Azienda Osped, Ist Ematol, Bologna, Italy
[5] Japanese Red Cross Med Ctr, Div Hematol, Tokyo, Japan
[6] Sanofi, Cambridge, MA USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA
[8] Centrum Hamatol & Onkol Bethanien, Frankfurt, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1109
引用
收藏
页码:316 / 316
页数:1
相关论文
empty
未找到相关数据